Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unicycive Therapeutics (UNCY) Amortizatization of Intangibles (2020 - 2026)

Unicycive Therapeutics filings provide 3 years of Amortizatization of Intangibles readings, the most recent being $127000.0 for Q4 2024.

  • On a quarterly basis, Amortizatization of Intangibles rose 60.76% to $127000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $406000.0, a 47.64% increase, with the full-year FY2025 number at $500000.0, up 23.15% from a year prior.
  • Amortizatization of Intangibles hit $127000.0 in Q4 2024 for Unicycive Therapeutics, up from $117000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $275000.0 in Q1 2024 to a low of -$113000.0 in Q2 2024.
  • Median Amortizatization of Intangibles over the past 3 years was $59500.0 (2023), compared with a mean of $69583.3.
  • The widest YoY moves for Amortizatization of Intangibles: up 539.53% in 2024, down 248.68% in 2024.
  • Unicycive Therapeutics' Amortizatization of Intangibles stood at $40000.0 in 2022, then skyrocketed by 97.5% to $79000.0 in 2023, then skyrocketed by 60.76% to $127000.0 in 2024.
  • The last three reported values for Amortizatization of Intangibles were $127000.0 (Q4 2024), $117000.0 (Q3 2024), and -$113000.0 (Q2 2024) per Business Quant data.